Search results
What is Ecstasy? Ecstasy (MDMA, 3,4 methylenedioxymethamphetamine), also commonly called Molly, is a synthetic (lab made), psychoactive drug chemically similar to the stimulant methamphetamine and the hallucinogen mescaline.
What is ECSTASY/MDMA? Ecstasy/MDMA acts as both a stimulant and hallucinogen, producing an energizing effect, distortions in time and perception, and enhanced enjoyment of tactile experiences. Adolescents and young adults use it to reduce inhibitions and to promote: • Euphoria, feelings of closeness, empathy, and sexuality.
- nida.nih.gov
- › …
- › MDMA (Ecstasy) Abuse Research Report
MDMA is a synthetic drug that acts as a stimulant and hallucinogen. 15–17 It produces an energizing effect, distortions in time and perception, and enhanced enjoyment from sensory experiences. It has also been described as an entactogen—a drug that can increase self-awareness and empathy. 1,2,18. Ecstasy is often used to refer to MDMA in ...
- nida.nih.gov
- › Research Topics
Apr 19, 2024 · Highlights. MDMA, also called Molly or Ecstasy, is a lab-made (synthetic) drug that has effects similar to stimulants like methamphetamine. Some researchers and organizations consider MDMA to be a psychedelic drug because it can also mildly alter visual and time perception.
Jun 5, 2020 · DEA's revised and updated drug fact sheet about MDMA, also known as ecstasy - what it is, what is its origin, what common street names for these drugs, what does it look like, how it is abused, what their effect is on the mind and bodies of users including signs of overdose, and its legal status.
May 5, 2024 · Ecstasy, which is taken in pill or powder form, also has a chemical relationship to the psychedelic drug mescaline. Developed in 1913 as an appetite suppressant and patented by Merck & Co. the following year, the drug was not originally approved for release.
Aug 18, 2023 · Aug. 18, 2023. Leer en español. Over the last few years, MDMA, also known as Ecstasy or Molly, has increasingly become associated with therapy and healing and could be approved next year by the...
